Figure 4: RPPA data from TCGA GBM samples.
From: Metabolic/Proteomic Signature Defines Two Glioblastoma Subtypes With Different Clinical Outcome
Boxplots of standardized levels of RPPA analytes measured in P (proneural, n = 41, pink) and M (mesemchymal, n = 29, red) samples selected from the full cohort (n = 214) of GBM tumors that was subjected to RPPA analysis within the TCGA consortium. The RPPA endpoints reported here were selected based on the presence, in the TCGA data, of analytes matching the GSf- (A, yellow box), or GSr-like (B, brown box) lists defined by our RPPA analysis (see methods sections for details). P values from unpaired t test are reported on top of each endpoint plot.
